Key statistics
SmartText not available for this item.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 0.482 |
Low | 0.482 |
Bid | -- |
Offer | -- |
Previous close | 0.482 |
Average volume | -- |
---|---|
Shares outstanding | 767.16m |
Free float | 609.04m |
P/E (TTM) | 5.91 |
Market cap | 1.02bn HKD |
EPS (TTM) | 0.2249 HKD |
Data delayed at least 15 minutes, as of Apr 13 2022.
More ▼
Press releases
- Harbour BioMed Announces Publication of the Phase I Study Results for Porustobart in Combination with Toripalimab in Advanced Melanoma and Other Solid Tumors
- Harbour BioMed Announces the Latest Clinical Data on the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024
- Harbour BioMed Announces 2024 Interim Results
- Harbour BioMed to Present the Latest Progress of the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024
- Harbour BioMed Announces Positive Profit Alert for 2024 Interim Results
More ▼